Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency

M W Linder1, R A Prough, R Valdes

  • 1Department of Pathology, University of Louisville School of Medicine, KY 40292, USA.

Clinical Chemistry
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrodynamic cavitation through a bio-inspired fast-closing plunger mechanism: experiments and simulations.

Bioinspiration & biomimetics·2022
Same author

Two-color pyrometry for low amplitude periodic heating.

The Review of scientific instruments·2017
Same author

Coating thermal diffusivity and effusivity measurement optimization using regression-based sensitivity.

The Review of scientific instruments·2015
Same author

Identification of Environmental Chemicals Associated with the Development of Toxicant-associated Fatty Liver Disease in Rodents.

Toxicologic pathology·2014
Same author

Release of targeted p53 from the mitochondrion as an early signal during mitochondrial dysfunction.

Cellular signalling·2013
Same author

Improvements to surrogate data methods for nonstationary time series.

Physical review. E, Statistical, nonlinear, and soft matter physics·2012
Same journal

From Pooled Cohorts to PREVENT: A Perspective for Clinical Laboratorians.

Clinical chemistry·2026
Same journal

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

Clinical chemistry·2026
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
See all related articles

Pharmacogenetics links an individual's genes to drug metabolism, preventing adverse reactions. Genotyping drug-metabolizing enzymes like CYP2D6 improves drug safety and effectiveness.

Area of Science:

  • Pharmacogenetics
  • Clinical Pharmacology
  • Genomics

Background:

  • Individual differences in drug metabolism arise from genetic variations (polymorphisms) in drug-metabolizing enzymes.
  • Altered drug metabolism can lead to severe toxicity or treatment failure due to unintended drug concentrations.
  • Pharmacogenetics aims to predict and manage these variations for safer and more effective drug therapy.

Purpose of the Study:

  • To review and update information on drug-metabolizing genotypes.
  • To emphasize cytochrome P-4502D6 (CYP2D6) genotyping techniques for clinical application.
  • To highlight the link between human genetics and therapeutic management.

Main Methods:

  • Genotyping of polymorphic alleles encoding drug-metabolizing enzymes.

Related Experiment Videos

  • Application of genotyping to identify an individual's drug metabolism phenotype.
  • Review of existing literature and techniques for CYP2D6 genotyping.

    • Main Results:

    • Genetic variations in drug-metabolizing enzymes significantly impact therapeutic outcomes.
    • CYP2D6 gene polymorphism affects drug management in a substantial portion of certain ethnic groups (up to 17%).
    • Genotyping provides a tool for personalized medicine, optimizing drug selection and dosage.

    Conclusions:

    • Pharmacogenetic testing, particularly CYP2D6 genotyping, is crucial for clinical laboratories.
    • Linking genetic information to therapeutic management enhances treatment efficiency and reduces adverse drug reactions.
    • Personalized dosing strategies based on pharmacogenetics improve patient safety and treatment efficacy.